3rd Quarter - Report

TIBER CREEK GROUP for ASTELLAS PHARMA US, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. Incentives for companies to develop anti-biotics/anti-infectives. H.R. 6331, Generating Antibiotic Incentives Now Act of 2010. Issues pertaining to community and hospital acquired infections (HAC). 340b program. Biosimilars. H.R. 2400, the Strategies to Address Antimicrobial Resistance Act. H.R.4213, American Jobs and Closing Tax Loopholes Act of 2010: 340b provisions.

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
SHEILA MURPHY —
SEAN RICHARDSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1458 (111th), H.R. 6331 (111th), H.R. 4213 (111th), H.R. 2400 (111th), S. 565 (111th)

Medicare/Medicaid MMM

H.R. 1458/S. 565, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009. Issues pertaining to community and hospital acquired infections (HAC).

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
SHEILA MURPHY —
SEAN RICHARDSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1458 (111th), S. 565 (111th)

Tariff (miscellaneous tariff bills) TAR

S. 2753, a bill to suspend temporarily the suspension of duty on RSD 1235.

Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration, has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has lobbied and listed above.

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
SHEILA MURPHY —
SEAN RICHARDSON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2753 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.